• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过电子病历系统建立高效的院内转诊体系,促进乙型肝炎病毒携带者向肝病专家转诊:一项针对 1281 名医疗保健专业人员的基于多中心问卷调查研究。

Establishing Efficient Systems through Electronic Medical Records to Promote Intra-hospital Referrals of Hepatitis Virus Carriers to Hepatology Specialists: A Multicenter Questionnaire-based Survey of 1,281 Healthcare Professionals.

机构信息

Department of Gastroenterology and Hepatology, Yamaguchi University Hospital, Japan.

Department of Hepatology, Osaka City University Hospital, Japan.

出版信息

Intern Med. 2021;60(3):337-343. doi: 10.2169/internalmedicine.4748-20. Epub 2021 Feb 1.

DOI:10.2169/internalmedicine.4748-20
PMID:33518608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7925281/
Abstract

Objective Persistent hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major causative factors of hepatic cirrhosis and hepatocellular carcinoma. However, the development of antiviral treatment has enabled their suppression. Therefore, the early detection and treatment of these infections are important. The objective of this study was to assess the level of awareness among healthcare professionals about hepatitis virus infection and electronic medical records alert system. Methods We surveyed healthcare professionals from 10 institutions with electronic medical records alert systems. All participants attended a lecture about the reactivation risk due to HBV infections, the most recent antiviral treatment for HCV infections, and the electronic medical records alert system. They participated in a questionnaire-based survey about their awareness of these infections, current status of intra-hospital referral, need for intra-hospital referrals before and after the lecture, and reasons for non-referral of patients to specialists. Results Responses were received from 1,281 healthcare professionals. Physicians and pharmacists had a high level of awareness about HBV and HCV. Among physicians, the level of awareness of those in the surgical field and other fields was significantly lower than that of the professionals in the internal medicine field. The awareness of the need to refer patients to hepatologists increased from 84.7-85.4% before to 93.0% after the lecture. The most frequent reasons for not referring patients previously were "I had no knowledge and/or interest" (28.1% of responses) and "All I did was explain the results orally" (24.2%). Conclusion More widespread education of healthcare personnel is important to increase the number of individuals receiving appropriate treatment from specialist physicians.

摘要

目的

乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)的持续感染是肝硬化和肝细胞癌的主要病因。然而,抗病毒治疗的发展使其得到了抑制。因此,早期检测和治疗这些感染非常重要。本研究的目的是评估医护人员对肝炎病毒感染和电子病历警示系统的认知水平。

方法

我们调查了 10 家拥有电子病历警示系统的医疗机构的医护人员。所有参与者都参加了关于 HBV 感染再激活风险、最新 HCV 感染抗病毒治疗以及电子病历警示系统的讲座。他们参与了一项基于问卷的调查,内容包括他们对这些感染的认识、院内转诊的现状、讲座前后院内转诊的需求以及未将患者转介给专家的原因。

结果

共收到 1281 名医护人员的回复。医生和药剂师对 HBV 和 HCV 的认识水平较高。在医生中,外科和其他领域医生的认知水平明显低于内科医生。将患者转介给肝病专家的意识从讲座前的 84.7%-85.4%增加到了 93.0%。以前未将患者转介的最常见原因是“我没有知识和/或兴趣”(28.1%的回复)和“我只是口头解释结果”(24.2%)。

结论

对医护人员进行更广泛的教育对于增加接受专科医生适当治疗的人数非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94a/7925281/10f34cf475d5/1349-7235-60-0337-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94a/7925281/af1ec05c7081/1349-7235-60-0337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94a/7925281/08591142db4b/1349-7235-60-0337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94a/7925281/a84527ba4adf/1349-7235-60-0337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94a/7925281/d1cc7e54f07f/1349-7235-60-0337-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94a/7925281/10f34cf475d5/1349-7235-60-0337-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94a/7925281/af1ec05c7081/1349-7235-60-0337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94a/7925281/08591142db4b/1349-7235-60-0337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94a/7925281/a84527ba4adf/1349-7235-60-0337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94a/7925281/d1cc7e54f07f/1349-7235-60-0337-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94a/7925281/10f34cf475d5/1349-7235-60-0337-g005.jpg

相似文献

1
Establishing Efficient Systems through Electronic Medical Records to Promote Intra-hospital Referrals of Hepatitis Virus Carriers to Hepatology Specialists: A Multicenter Questionnaire-based Survey of 1,281 Healthcare Professionals.通过电子病历系统建立高效的院内转诊体系,促进乙型肝炎病毒携带者向肝病专家转诊:一项针对 1281 名医疗保健专业人员的基于多中心问卷调查研究。
Intern Med. 2021;60(3):337-343. doi: 10.2169/internalmedicine.4748-20. Epub 2021 Feb 1.
2
Putting "sticky notes" on the electronic medical record to promote intra-hospital referral of hepatitis B and C virus-positive patients to hepatology specialists: an exploratory study.在电子病历上贴“便利贴”以促进医院内丙型和乙型肝炎病毒阳性患者转诊至肝病专科医生:一项探索性研究。
BMC Infect Dis. 2016 Aug 12;16:410. doi: 10.1186/s12879-016-1765-y.
3
What Can Be Done to Address the Exhaustive Referral of Patients with Viral Hepatitis to Specialists?如何应对病毒性肝炎患者过度转诊至专科医生的问题?
Intern Med. 2021 Feb 1;60(3):323-324. doi: 10.2169/internalmedicine.5967-20. Epub 2020 Sep 19.
4
Hepatitis C screening and referral for further investigation and treatment in a tertiary care hospital.在一家三级医院进行丙型肝炎筛查以及进一步检查和治疗的转介。
J Infect Dev Ctries. 2020 Jun 30;14(6):642-646. doi: 10.3855/jidc.12584.
5
Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar.缅甸医生对病毒性肝炎和肝细胞癌管理的看法。
PLoS One. 2017 Aug 10;12(8):e0181603. doi: 10.1371/journal.pone.0181603. eCollection 2017.
6
Knowledge, Attitudes, and Behaviors Related to Hepatitis C Screening and Treatment among Health Care Providers in Washington, DC.华盛顿特区医疗服务提供者中与丙型肝炎筛查及治疗相关的知识、态度和行为
J Community Health. 2020 Aug;45(4):785-794. doi: 10.1007/s10900-020-00794-z.
7
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
8
Promoting notification and linkage of HBs antigen and anti-HCV antibody-positive patients through hospital alert system.通过医院警报系统促进乙肝表面抗原和丙肝抗体阳性患者的通报与转诊。
BMC Infect Dis. 2017 May 8;17(1):330. doi: 10.1186/s12879-017-2438-1.
9
NIH consensus development statement on management of hepatitis B.美国国立卫生研究院关于乙型肝炎管理的共识发展声明。
NIH Consens State Sci Statements. 2008;25(2):1-29.
10
Prevention of Liver Cancer Through the Early Detection of Risk-related Behavior Among Hepatitis B or C Carriers.通过早期检测乙肝或丙肝携带者的风险相关行为预防肝癌
Cancer Nurs. 2015 May-Jun;38(3):169-76. doi: 10.1097/NCC.0000000000000153.

引用本文的文献

1
Testing, diagnosis of viral hepatitis, and the follow-up policy in Japan.日本的病毒性肝炎检测、诊断及随访政策。
Glob Health Med. 2021 Oct 31;3(5):308-313. doi: 10.35772/ghm.2021.01072.
2
Strategy for the Micro-Elimination of Hepatitis C among Patients with Diabetes Mellitus-A Hospital-Based Experience.糖尿病患者丙型肝炎微观消除策略——基于医院的经验
J Clin Med. 2021 Jun 6;10(11):2509. doi: 10.3390/jcm10112509.
3
Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study.

本文引用的文献

1
Countermeasures against viral hepatitis B and C in Japan: An epidemiological point of view.日本针对乙型和丙型病毒性肝炎的对策:流行病学视角
Hepatol Res. 2019 Sep;49(9):990-1002. doi: 10.1111/hepr.13417. Epub 2019 Aug 22.
2
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update.日本全国范围内非乙型、非丙型肝细胞癌的调查:2011-2015 年更新。
J Gastroenterol. 2019 Apr;54(4):367-376. doi: 10.1007/s00535-018-1532-5. Epub 2018 Nov 29.
3
Epidemiological Survey of Patients With Hemodialysis Complicated by Hepatitis C in Japan.
丙型肝炎微消除系统中失访患者的找回:一项单中心回顾性研究。
BMC Gastroenterol. 2021 May 8;21(1):209. doi: 10.1186/s12876-021-01792-8.
4
What Can Be Done to Address the Exhaustive Referral of Patients with Viral Hepatitis to Specialists?如何应对病毒性肝炎患者过度转诊至专科医生的问题?
Intern Med. 2021 Feb 1;60(3):323-324. doi: 10.2169/internalmedicine.5967-20. Epub 2020 Sep 19.
日本血液透析合并丙型肝炎患者的流行病学调查
Ther Apher Dial. 2019 Feb;23(1):44-48. doi: 10.1111/1744-9987.12747. Epub 2018 Aug 20.
4
EASL Recommendations on Treatment of Hepatitis C 2018.2018年欧洲肝脏研究学会丙型肝炎治疗推荐意见
J Hepatol. 2018 Aug;69(2):461-511. doi: 10.1016/j.jhep.2018.03.026. Epub 2018 Apr 9.
5
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression.直接作用抗病毒 HCV 治疗后肝细胞癌风险:系统评价、荟萃分析和荟萃回归。
J Hepatol. 2017 Dec;67(6):1204-1212. doi: 10.1016/j.jhep.2017.07.025. Epub 2017 Aug 9.
6
Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers.基层医疗中电子健康记录警报对增加婴儿潮一代丙型肝炎筛查和治愈性治疗的影响。
Hepatology. 2017 Dec;66(6):1805-1813. doi: 10.1002/hep.29362. Epub 2017 Sep 14.
7
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.直接作用抗病毒药物治疗的 HCV 患者的肝细胞癌风险。
Gastroenterology. 2017 Oct;153(4):996-1005.e1. doi: 10.1053/j.gastro.2017.06.012. Epub 2017 Jun 19.
8
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.EASL 2017 临床实践指南:乙型肝炎病毒感染管理。
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
9
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.2015 年全球丙型肝炎病毒感染的流行率和基因型分布:一项建模研究。
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. doi: 10.1016/S2468-1253(16)30181-9. Epub 2016 Dec 16.
10
Current activities and future directions of comprehensive hepatitis control measures in Japan: The supportive role of the Hepatitis Information Center in building a solid foundation.日本综合肝炎防控措施的当前活动及未来方向:肝炎信息中心在奠定坚实基础方面的支持作用
Hepatol Res. 2017 May;47(6):487-496. doi: 10.1111/hepr.12897. Epub 2017 Apr 25.